What is the share price of Ecofinity Atomix Ltd (ARYAVAN) today?
The share price of ARYAVAN as on 18th March 2025 is ₹42.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ecofinity Atomix Ltd (ARYAVAN) share?
The past returns of Ecofinity Atomix Ltd (ARYAVAN) share are- Past 1 week: -11.98%
- Past 1 month: -15.38%
- Past 3 months: -25.45%
- Past 6 months: -18.31%
- Past 1 year: 12.55%
- Past 3 years: 261.28%
- Past 5 years: 263.48%
What are the peers or stocks similar to Ecofinity Atomix Ltd (ARYAVAN)?
The peers or stocks similar to Ecofinity Atomix Ltd (ARYAVAN) include:What is the market cap of Ecofinity Atomix Ltd (ARYAVAN) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ecofinity Atomix Ltd (ARYAVAN) is ₹25.45 Cr as of 18th March 2025.What is the 52 week high and low of Ecofinity Atomix Ltd (ARYAVAN) share?
The 52-week high of Ecofinity Atomix Ltd (ARYAVAN) is ₹69.74 and the 52-week low is ₹32.94.What is the PE and PB ratio of Ecofinity Atomix Ltd (ARYAVAN) stock?
The P/E (price-to-earnings) ratio of Ecofinity Atomix Ltd (ARYAVAN) is 90.88. The P/B (price-to-book) ratio is 7.73.Which sector does Ecofinity Atomix Ltd (ARYAVAN) belong to?
Ecofinity Atomix Ltd (ARYAVAN) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ecofinity Atomix Ltd (ARYAVAN) shares?
You can directly buy Ecofinity Atomix Ltd (ARYAVAN) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ecofinity Atomix Ltd
ARYAVANEcofinity Atomix Ltd
ARYAVAN
Health CarePharmaceuticals
SmallcapWith a market cap of ₹25 cr, stock is ranked 3,963
High RiskStock is 4.31x as volatile as Nifty
42.902.63% (+1.10)
42.902.63% (+1.10)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 39.15 | 7.73 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.31 | 6.04 | 0.55% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Ecofinity Atomix Limited focuses on manufacturing pharmaceutical products, contributing to the healthcare sector with its offerings.
Peers
Compare with peersSUNPHARMA
PE Ratio
42.70
1Y Return
8.47%
Buy Reco %
88.24
CIPLA
PE Ratio
29.25
1Y Return
0.28%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
62.65
1Y Return
19.33%
Buy Reco %
68.00
DRREDDY
PE Ratio
17.19
1Y Return
9.27%
Buy Reco %
45.16
LUPIN
PE Ratio
47.50
1Y Return
23.38%
Buy Reco %
63.64
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.44 | 3.17 | 0.49 | 1.00 | 0.43 | 0.03 | 0.27 | 0.26 | 6.75 | 9.95 | ||||||||||
Raw Materials | 0.35 | 2.74 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.31 | 9.10 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Employee Cost | 0.01 | 0.03 | 0.02 | 0.02 | 0.05 | 0.01 | 0.02 | 0.01 | 0.02 | |||||||||||
| Selling & Administrative Expenses | 0.08 | 0.08 | 0.06 | 0.02 | 0.07 | 0.14 | 0.05 | 0.11 | 0.16 | |||||||||||
| Operating & Other expenses | 0.04 | 0.08 | 0.00 | 0.74 | 0.30 | 0.01 | 0.20 | 0.40 | -1.03 | |||||||||||
EBITDA | -0.04 | 0.24 | 0.03 | 0.22 | 0.01 | -0.13 | 0.00 | -0.26 | 0.29 | 0.85 | ||||||||||
| Depreciation/Amortization | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | ||||||||||
| PBIT | -0.08 | 0.24 | 0.03 | 0.22 | 0.01 | -0.13 | 0.00 | -0.26 | 0.29 | 0.81 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | ||||||||||
| PBT | -0.08 | 0.24 | 0.03 | 0.22 | 0.01 | -0.13 | 0.00 | -0.26 | 0.29 | 0.79 | ||||||||||
| Taxes & Other Items | 0.00 | 0.02 | 0.01 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.14 | ||||||||||
| Net Income | -0.08 | 0.22 | 0.02 | 0.15 | 0.01 | -0.13 | 0.00 | -0.26 | 0.28 | 0.65 | ||||||||||
| EPS | -0.21 | 0.57 | 0.05 | 0.39 | 0.03 | -0.34 | 0.00 | -0.68 | 0.73 | 1.69 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Company Updates
FY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFPeers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ecofinity Atomix Ltd | 90.88 | 7.73 | — |
| Sun Pharmaceutical Industries Ltd | 42.70 | 6.09 | 0.79% |
| Cipla Ltd | 29.25 | 4.50 | 0.87% |
| Torrent Pharmaceuticals Ltd | 62.65 | 15.14 | 0.91% |
Price Comparison
Compare ARYAVAN with any stock or ETFCompare ARYAVAN with any stock or ETF
ARYAVAN
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 29.19%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ARYAVAN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Earnings
Ecofinity Atomix standalone net profit rises 200.00% in the December 2024 quarter
Net profit of Ecofinity Atomix rose 200.00% to Rs 0.24 crore in the quarter ended December 2024 as against Rs 0.08 crore during the previous quarter ended December 2023. Sales rose 329.59% to Rs 7.26 crore in the quarter ended December 2024 as against Rs 1.69 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales7.261.69 330 OPM %3.030 - PBDT0.320.08 300 PBT0.320.08 300 NP0.240.08 200 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Ecofinity Atomix to announce Quarterly Result
Ecofinity Atomix will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Ecofinity Atomix standalone net profit rises 212.50% in the September 2024 quarter
Net profit of Ecofinity Atomix rose 212.50% to Rs 0.25 crore in the quarter ended September 2024 as against Rs 0.08 crore during the previous quarter ended September 2023. Sales rose 1782.35% to Rs 6.40 crore in the quarter ended September 2024 as against Rs 0.34 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales6.400.34 1782 OPM %4.535.88 - PBDT0.330.08 313 PBT0.330.08 313 NP0.250.08 213 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Ecofinity Atomix to convene EGM
Ecofinity Atomix announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 16 October 2024 .Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Ecofinity Atomix to hold board meeting
Ecofinity Atomix will hold a meeting of the Board of Directors of the Company on 20 September 2024.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Ecofinity Atomix reports standalone net profit of Rs 0.25 crore in the June 2024 quarter
Net profit of Ecofinity Atomix reported to Rs 0.25 crore in the quarter ended June 2024 as against net loss of Rs 0.03 crore during the previous quarter ended June 2023. Sales reported to Rs 6.48 crore in the quarter ended June 2024. There were no Sales reported during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales6.480 0 OPM %4.480 - PBDT0.34-0.03 LP PBT0.34-0.03 LP NP0.25-0.03 LP Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Ecofinity Atomix to discuss results
Ecofinity Atomix will hold a meeting of the Board of Directors of the Company on 6 August 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 46.51%, vs industry avg of 9.04%
Constant Market Share
Over the last 5 years, market share stayed at 0%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 13.3%, vs industry avg of 15.28%